No inexplicable disagreements between real-world data–based nonrandomized controlled studies and randomized controlled trials were found-Reference-Cited by-同舟云学术

No inexplicable disagreements between real-world data–based nonrandomized controlled studies and randomized controlled trials were found

Published:2021-05 Issue: Volume:133 Page:1-13
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Mathes Tim,Rombey Tanja,Kuss Oliver,Pieper Dawid^ORCID

Publisher

Elsevier BV

Subject

Epidemiology

Reference36 articles.

1. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials;Anglemyer;Cochrane Database Syst Rev,2014

2. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey;Hemkens;BMJ,2016

3. Comparison of population-based observational studies with randomized trials in oncology;Soni;J Clin Oncol,2019

4. Meta-analyses frequently pooled different study types together: a meta-epidemiological study;Bun;J Clin Epidemiol,2020

5. The reporting of studies using routinely collected health data was often insufficient;Hemkens;J Clin Epidemiol,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Problematic meta-analyses: Bayesian and frequentist perspectives on combining randomized controlled trials and non-randomized studies;BMC Medical Research Methodology;2024-04-27

2. Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention;BMC Medical Informatics and Decision Making;2024-02-02

3. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study;Cochrane Database of Systematic Reviews;2024-01-04

4. An empirical comparison of the harmful effects for randomized controlled trials and non-randomized studies of interventions;Frontiers in Pharmacology;2023-03-21

5. Partially randomised, patient preference trials for inflammatory bowel disease;The Lancet Gastroenterology & Hepatology;2022-11